Patient Guide: Frespaciguat (MK-5475) INSIGNIA-PH-COPD: A Study of the Efficacy and Safety of Frespaciguat (an Inhaled sGC Stimulator) in Adults With PH-COPD

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 84 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05612035
Status: 🟢 Enrolling Now
Condition: Pulmonary Hypertension, Chronic Obstructive Pulmonary Disease
Phase: PHASE2

Where You Can Participate

This study is available at 84 locations across the country.

Top locations include:
  • • San Francisco, California
  • • Aurora, Colorado
  • • Sebring, Florida
  • • And 81 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Frespaciguat (MK-5475) INSIGNIA-PH-COPD: A Study of the Efficacy and Safety of Frespaciguat (an Inhaled sGC Stimulator) in Adults With PH-COPD - Join Clinical Trial NCTNCT05612035

How to Join This Clinical Trial - NCTNCT05612035

Learn how to participate in this PHASE2 trial studying an investigational therapy for Pulmonary Hypertension, Chronic Obstructive Pulmonary Disease. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Pulmonary Hypertension, Chronic Obstructive Pulmonary Disease. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Pulmonary Hypertension, Chronic Obstructive Pulmonary Disease
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05612035 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 84 locations. Find a study site near you:

Clinical Research Site

San Francisco, California 94143 - United States

Status: RECRUITING

Clinical Research Site

Aurora, Colorado 80045 - United States

Status: RECRUITING

Clinical Research Site

Sebring, Florida 33870 - United States

Status: COMPLETED

Clinical Research Site

Elk Grove Village, Illinois 60007 - United States

Status: COMPLETED

Clinical Research Site

Iowa City, Iowa 52242 - United States

Status: RECRUITING

Clinical Research Site

Kansas City, Kansas 66160 - United States

Status: RECRUITING

Clinical Research Site

Lexington, Kentucky 40502 - United States

Status: RECRUITING

Clinical Research Site

Grand Rapids, Michigan 49546 - United States

Status: RECRUITING

Clinical Research Site

Rochester, Minnesota 55905 - United States

Status: RECRUITING

Clinical Research Site

Omaha, Nebraska 68124 - United States

Status: COMPLETED

And 74 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Pulmonary Hypertension, Chronic Obstructive Pulmonary Disease:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships